子宫内膜癌筛查临床与病理最新章节_李奇灵著

参考文献

［1］ Koh WJ，Abu-Rustum NR，Bean S，et al.Uterine Neoplasms，Version 1.2018，NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network：JNCCN，2018，16（2）：170-199.

［2］廖秦平，杨曦.子宫内膜癌筛查及早期诊断的现状及展望.实用妇产科杂志，2015，031（007）：481-484.

［3］ Bokhman JV.Two pathogenetic types of endometrial carcinoma.Gynecologic oncology，1983，15（1）：10-17.

［4］ Felix AS，Weissfeld JL，Stone RA，et al.Factors associated with Type Ⅰ and Type Ⅱ endometrial cancer.Cancer causes & control：CCC，2010，21（11）：1851-1856.

［5］ Renehan AG，Tyson M，Egger M，et al.Body-mass index and incidence of cancer：a systematic review and meta-analysis of prospective observational studies.Lancet，2008，371（9612）：569-578.

［6］ Pellerin GP，Finan MA.Endometrial cancer in women 45 years of age or younger：a clinicopathological analysis.American journal of obstetrics and gynecology，2005，193（5）：1640-1644.

［7］ Sponholtz TR，Palmer JR，Rosenberg L，et al.Body Size，Metabolic Factors，and Risk of Endometrial Cancer in Black Women.American journal of epidemiology，2016，183（4）：259-268.

［8］ Fader AN，Arriba LN，Frasure HE，et al.Endometrial cancer and obesity：epidemiology，biomarkers，prevention and survivorship.Gynecologic oncology，2009，114（1）：121-127.

［9］ Win AK，Reece JC，Ryan S.Family history and risk of endometrial cancer：a systematic review and meta-analysis.Obstetrics and gynecology，2015，125（1）：89-98.

［10］ Lancaster JM，Powell CB，Chen LM，et al.Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.Gynecologic oncology，2015，136（1）：3-7.

［11］ Schmeler KM，Lynch HT，Chen LM，et al.Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.The New England journal of medicine，2006，354（3）：261-269.

［12］ Dashti SG，Chau R，Ouakrim DA，et al.Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.Jama，2015，314（1）：61-71.

［13］ Heald B，Mester J，Rybicki L，et al.Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.Gastroenterology，2010，139（6）：1927-1933.

［14］ Winer I，Lehman A，Wactawski-Wende J，et al.Tubal Ligation and Risk of Endometrial Cancer：Findings From the Women's Health Initiative.International journal of gynecological cancer：official journal of the International Gynecological Cancer Society，2016，26（3）：464-471.

［15］ Iqbal J，Ginsburg OM，Wijeratne TD，et al.Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer：a systematic review.Cancer treatment reviews，2012，38（4）：318-328.